chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A temperature of 103.8 for more then 5 hours, excessive tiredness, swelling of the face and neck area. Extreme weakness
Got worst case of shingles which lasted for MONTHS; This case was reported by a consumer via interactive digital media  and described the occurrence of shingles in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several weeks after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows The case was reported by the patient's friend. The age at vaccination was not reported. The patient received Shingles vaccine on the advice of her medical professional. A couple of weeks after receiving Shingles vaccine, the patient had worst case of shingles she would ever had which lasted for months. The patient had trouble with shingles. The patient advised the reporter not to get the Shingles vaccine. The reporter took her advice. The reporter stated that, without looking, he/she would take bets this was encouraging folks to get the Shingles vaccine.
Muscle aches, Chills, Lethargic Narrative:  Other Relevant History:
About 10 minutes after shot I got little dizzy. throughout the next 24 hours I had severe muscle and joint pain. 1/11-1/14 I had headaches and minor joint and muscle pain. 1/15 I checked my temp and I have a fever 100.6 and I have a sever headache.
1JUL92 recvd 1st dose of Engerix-B & 11JUL92 donated blood & was found to have a pos Hep C test;
Shortness of breath, heart racing. Started 11/27, lasted through 12/4. Was worst on 11/30.   On 11/30, started feeling this way around 11am at work. Got progressively worse through day into early evening. Went to ER around 7-8pm and was observed overnight. Pulse reached 140s/150s during periods, sustained in the 110s-120s most of the time. Shortness of breath felt the entire time, as well as great discomfort from fast heart rate. Was hyper aware of heartbeat, could physically feel it thumping constantly. Discharged from hospital midday on 12/1 after tests showed nothing of concern. Symptoms progressively got better over the course of the rest of the week.
1 or 2 days after shot in left shoulder began to feel bursitis in shoulder, arm didn't feel right, weakness, itching, muscle ache/tightness up to neck across shoulder blade, pain in shoulder joint/shoulder blade, arm felt a little like hitting the "funny bone" (hard to describe). No redness at shot site, no rash, nothing on skin. Also existing tinnitus worsened starting a day or two after shot. Still having all these symptoms 6 weeks after her first shot. Rescheduled 2nd shot to 6 week limit to buy time in the hope symptoms would go away. Had to cancel 2nd shot until I can sort this out or get more info.
Had a heartache and chest pain since 22:30 that hasn't vanished so far. Slightly sore around injection area on the left arm but it is bearabe.
Fever; Felt nauseous; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and NAUSEA (Felt nauseous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and NAUSEA (Felt nauseous). At the time of the report, PYREXIA (Fever) and NAUSEA (Felt nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    Concomitant information use was not reported.  Treatment information was not provided.
Feverish - no temp taken. Gave ADVIL for comfort. No c/o about arm unless touched. Playing and eating normally. 7 X 6 redness and induration.
Nausea, weakness, chills. More than what they reported on possible side effects. Got shot on 3/22/21. Started having vertigo yesterday 4/4/2021. Never had this issue before. Completely healthy no underlying conditions and no history of vertigo. All started after moderna shot.
pt had vax 24OCT94 in the afternoon; few hrs p/had chills & mild fever w/c has lasted till this visit; no other signs of infect;
15 minutes after giving VZV pt became SOB. She also had a large local reaction 5", chest had tightness and bilateral wheezings. Epi given and nebulizer albuterol. Pt improved. Pt has exercise induced asthma.
Patient called the pharmacy on 9/25/19 and said she has been sick since the day she received her flu shot(9/19/19). She reported  nausea, vomiting, fever, chills, severe soreness at injection site, headache, and fatigue. She said shortly after she arrived home, the headache began (~1 hr after vaccination) then the others followed and lasted for days. She said she is feeling better now and "on the mend." She didn't reach out to her primary doctor, the pharmacist recommended for her to contact her doctor.
Also, itching rash on arms, back, neck. Edema with redness & multiple papules. Not varicella in nature. Pt received SOLUMEDROL 80 mg. IM & MEDROL dose pack.
This spontaneous report as received from a pharmacist refers to a 60 year old female patient with no drug reactions/allergies. On 06-AUG-2013 the patient was vaccinated with ZOSTAVAX (lot # J002241, exp. 21-MAY-2014), 0.65 ml, subcutaneous. This pharmacist noted that the patient experienced an injection site reaction after ZOSTAVAX administration. This patient called this pharmacist today to report that in the morning, on 08-AUG-2013, she noted her unspecified injection site had some redness, swelling and tenderness to touch. No treatment was given. No lab diagnostics studies were performed. The outcome of injection site tenderness to touch, injection site swelling and injection site some redness was reported as recovering. Additional information has been requested.
Initial unsolicited report received from a nurse on 11 May 2015. A male patient, whose medical history and concomitant medications were not reported, had received a third dose of PENTACEL (batch number: C4871AB, expiry date: 12 September 2015 and dose not reported) intramuscularly in right thigh and also received a dose of HEP A (batch number, expiry date, dose, dose number, route of administration were not reported) in left thigh, both administered on 06 May 2015. It was reported that, on 08 May (unspecified year) patient mother brought the patient to doctor office with the red rash on the abdomen and right leg. On 11 May (unspecified year) during second examination, rash was reported to have decreased but was still present. It was reported that, patient required emergency room/doctor visit. Patient had no Illness at the time of vaccination and preexisting physician diagnosed allergies, birth defects, medical conditions. Laboratory investigations and corrective treatments were not reported. At the time of this report, patient was recovering from the event. Documents held by sender: none.
vertigo; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in arm left, administration date 15Mar2021 (Lot number: EL3247) at the age of 54 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "diabetes" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing), notes: due to full thyroidectomy; "full thyroidectomy" (unspecified if ongoing). Concomitant medications included: SYNTHROID; PROVIGIL [CHORIONIC GONADOTROPHIN]; LIOTHYRONINE; METFORMIN. Vaccination history included: BNT162B2 (dose 1, administered in the left arm, Batch/Lot number: EL3247), administration date: 22Feb2021, when the patient was 54 years old, for COVID-19 immunisation. The following information was reported: VERTIGO (non-serious) with onset 17Apr2021, outcome "recovered" (Apr2021), described as "vertigo".  Additional information: The report was received from a Pfizer colleague, who is also the patient.  No follow-up attempts are possible. No further information is expected.
third dose of Comirnaty; blood clot; itching on the side of her heart (further clarified that it was a sudden sensation on the left side of her chest, next to her breast); She also reports a dry throat; a cough; a lot of bone pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 48 year-old female patient received bnt162b2 (COMIRNATY) (Lot number: 331308A) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 immunization; Bnt162b2 (Dose 2), for Covid-19 immunization. The following information was reported: IMMUNISATION (medically significant) with onset 13Jan2022, outcome "unknown", described as "third dose of Comirnaty"; THROMBOSIS (medically significant) with onset 13Jan2022, outcome "unknown", described as "blood clot"; PRURITUS (non-serious) with onset 13Jan2022, outcome "unknown", described as "itching on the side of her heart (further clarified that it was a sudden sensation on the left side of her chest, next to her breast)"; DRY THROAT (non-serious) with onset 13Jan2022, outcome "unknown", described as "She also reports a dry throat"; COUGH (non-serious) with onset 13Jan2022, outcome "unknown", described as "a cough"; BONE PAIN (non-serious) with onset 13Jan2022, outcome "unknown", described as "a lot of bone pain".  Clinical course: Caller was a 48 year old female who got her third dose of Comirnaty on Wednesday. Yesterday, she had the following side effects begin: itching on the side of her heart (further clarified that it was a sudden sensation on the left side of her chest, next to her breast). She reported that it comes and goes. She had a blood clot last year, and she was asking what she should do about this. She also reports a dry throat, a cough, and a lot of bone pain. The reporter considered events as non serious.
Patient visited pharmacy 11/19/2009 and stated there was still a red spot (approx size of dime) at injection site. Vaccine was given 10/7/09. Referred her to primary physician and told her she could apply either BENADRYL or hydrocortisone cream to injection site.
rheumatism flair up; This spontaneous case was reported by a consumer and describes the occurrence of RHEUMATIC DISORDER (rheumatism flair up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RHEUMATIC DISORDER (rheumatism flair up). At the time of the report, RHEUMATIC DISORDER (rheumatism flair up) outcome was unknown.            Treatment and concomitants were not provided.
This spontaneous report as received from a physician via Company Representative refers to a male patient of unknown age. On an unknown date the patient was vaccinated with a second dose of PNEUMOVAX23 (lot # not reported) (start date, dose and route not reported). It was reported that the patient developed a 102F fever and had a "slight reaction" at the injection site. The patient was seen at the physician's office, on an unspecified date, regarding his symptoms. The physician reported the patient being recovered but the date of recovery was unspecified. Additional information has been requested.
Numbness of arms and feet. Sometimes it hurts but mostly feels like I am walking on bubble wrap. Going to see neurologist soon about it since podiatrist tested me for diabetes and that came back negative. I wake up and my legs and arms are stiff. My left side seems worse then my right side. Feels like a circulation problem. I still function normal but it is a problem that was not there before the vaccine.
Pt proceeded through immunization line to receive required vaccinations and Bicillin injection. Approximately 5 minutes after receiving immunizations and Bicillin injection, Pt stated she was having chest pain, and shortness of breath. Pt immediately taken to clinic provider, audible wheezing noted, vs stable. Provider called for EMS and gave pt 0.5ml epi subq with improvement of wheezing and chest pain. EMS arrived, IV started and EMS gave pt 50mg IV Benadryl. Pt trasnferred to ER for follow on treatment.
mildly sore on the arms on injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (mildly sore on the arms on injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (mildly sore on the arms on injection site). At the time of the report, VACCINATION SITE PAIN (mildly sore on the arms on injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided
feel pain; swelling in her armpit left area; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (feel pain) and PERIPHERAL SWELLING (swelling in her armpit left area) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. can't find it) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (feel pain) and PERIPHERAL SWELLING (swelling in her armpit left area). Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.   Reporter did not allow further contact
Information has been received from an unspecified type reporter from doctor's office via Pfizer referring to a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medication were not reported. On an unknown date in 2006 the patient was vaccinated with a dose of pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (dose, route, lot # and expiration date were unknown). On an unknown date the patient experienced a pretty severe allergic reaction, her arm was red and swollen. Outcome of the event was unknown. The reporter considered the allergic reaction to be related to Pneumococcal Vaccine, Polyvalent (23-valent) (manufacturer unknown). Additional information has been requested.
24hr p/vax pt devel fever, vomit, diarrhea, high pitched crying suspected sepsis;
Nauseated; Chills; Joint pain; Ears ringing; I feel awful/feel so bad; My vision is blurred; I am so sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 13Jan2022 (Lot number: FD7218) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization.  The following information was reported: NAUSEA (non-serious) with onset Jan2022, outcome "unknown", described as "Nauseated"; CHILLS (non-serious) with onset Jan2022, outcome "unknown", described as "Chills"; ARTHRALGIA (non-serious) with onset Jan2022, outcome "unknown", described as "Joint pain"; TINNITUS (non-serious) with onset Jan2022, outcome "unknown", described as "Ears ringing"; FEELING ABNORMAL (non-serious) with onset Jan2022, outcome "unknown", described as "I feel awful/feel so bad"; VISION BLURRED (non-serious) with onset Jan2022, outcome "unknown", described as "My vision is blurred"; ILLNESS (non-serious) with onset Jan2022, outcome "unknown", described as "I am so sick".  Additional information: When patient was asked about lot number, they reported Pfizer FD7218 or 51 and don't know.  Follow-up attempts completed. No further information expected.
Injection site reaction on left upper arm with pain and redness. Began 2 days after shot was given. Treatment: Elidel Cream bid to rash and Zithromax suspension 250 mg 1/2 tsp po qd for 7 days.
The patient developed a rash on her scalp and on her cheeks. She had an itchy scalp and back of neck.
Very hard to walk; Pain in feet, awful, it moves around; Pain got worse after 2nd dose; This non-serious case was reported by a consumer and described the occurrence of gait disturbance in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (The first dose was received on August 2022. refer this case - US2023011057). Concurrent medical conditions included foot pain and walking difficulty.   In DEC-2022, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced gait disturbance (Verbatim: Very hard to walk), foot pain (Verbatim: Pain in feet, awful, it moves around) and condition aggravated (Verbatim: Pain got worse after 2nd dose). Rechallenge with Shingrix was positive. The outcome of the gait disturbance, foot pain and condition aggravated were not recovered/not resolved.   It was unknown if the reporter considered the gait disturbance, foot pain and condition aggravated to be related to Shingrix.     It was unknown if the company considered the gait disturbance, foot pain and condition aggravated to be related to Shingrix.   Linked case(s) involving the same patient:  US2023011057   Additional Information: Additional Information: GSK Receipt Date: 01-MAR-2023 The patient stated that, she begin with the pains in her feet were from the Shingrix shot until she got the second one (shot) and it got even worsen. The patient went to multiple physician and had many blood tests.  Everything was normal and physician could not figure it out until she had the second shot. The pains in both her feet mostly the left had been awful, very hard to walk. It moved around so the patient  never know where the pain was going to be from day to day.; Sender's Comments:  US-GSK-US2023011057:Same reporter
Information has been received from a registered nurse concerning a 18 year old female who on 03-AUG-2007 was vaccinated 0.5mL, IM with a 1st dose of GARDASIL (lot# 655165/1425F). On 18-Oct-2007 the patient was vaccinated 0.5mL, IM with a 2nd dose of GARDASIL (lot# 657621/0387U). There was no concomitant medication. Subsequently the patient had a positive panpanicolaou test on 10-MAR-2008. The patient sought unspecified medical attention in her physician's office. It was reported that the patient had not been sexually active since previous papanicolaou test one year ago. Additional information has bee requested. No further information is expected.
Hidradenitis suppurativa; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of HIDRADENITIS (Hidradenitis suppurativa) and INFLUENZA LIKE ILLNESS (Flu like symptoms) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Hidradenitis suppurativa.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced HIDRADENITIS (Hidradenitis suppurativa) and INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, HIDRADENITIS (Hidradenitis suppurativa) had not resolved and INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Patient reported non-serious events hidradenitis suppurativa flare up and covid vaccine reaction/had flu Like symptoms with HUMIRA (ADALIMUMAB).   On unknown dates, the patient experienced hidradenitis suppurativa flare up and covid vaccine reaction/had flu like symptoms. On an unknown date, covid vaccine reaction/had flu like symptoms resolved.   Covid-19 vaccine MODERNA (COVID-19 VACCINE MRNA (MRNA 1273)) was also considered suspect.  Treatment information was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
I can't sleep on my right arm. I have to roll over and there's time in the night where I have to put something on it because it's hurting bad. I can't do yardwork with my right arm. It's not getting any better. The more I would use it the better it would get. If I touch that area where the shot was given and it hurts. Pain still remains.
On 10/8/02 child got MMR and varivax in left leg and had cellulitis after immunization (initially 14cmx9cm on visit 10/11/02) treated with Augmentin markedly improved after a few days and resolved completely when antibiotics completed.
several months of decline in health followed by several visits to specialists - neurology, hepatology, infectious disease, rheumatology. symptoms: over 2 months - weight loss of 15 pounds, huge swollen cervical lymph nodes, difficulty initiating swallow, life altering weakness and exhaustion, extreme pain in shoulders, backs of arms, hips, tops of legs and buttocks. Eventual inability to walk. unable to perform daily tasks. inability to work. No appetite. Finally diagnosed as PMR (polymyalgia rheumatica) by a rheumatologist
REDNESS, SWELLING ON RT UPPER THIGH NOTE: ALSO RECEIVED A PPD SKIN TEST AT THE SAME TIME AS VACCINES, SANOFI C362999, RA.
Allergic reaction, hives on face and neck, eye and face swelling , all beginning the night of 4/10 and continuing
Excessive licking of hands, fingers, feet, toys, windows, doors, books and other people (cheeks, hands, arms).
diarrhea; This is a spontaneous report from a non-contactable consumer or other non hcp.     This is a spontaneous report from a non-contactable consumer (patient).  A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 25Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient experienced diarrhea (non-serious) on an unspecified date with outcome of unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.